SPINE
No significant improvement in back pain/disability with intranasal calcitonin intervention
Eur Spine J. 2006 Mar;15(3):356-62. Epub 2005 Sep 29110 postmenopausal osteoporotic women with chronic low back pain were randomised to receive either an intranasal salmon calcitonin with oral calcium intervention or an oral calcium intervention only. The patients were part of three groups, based on the presence of vertebral fractures, degenerative disorders, or non specific chronic back pain with no evidence of vertebral deformities.The primary outcome was back pain and disability. The results indicated that no significant improvement in pain and disability was observed with the intranasal calcitonin intervention.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
